Staar Surgical Company (STAA)
NASDAQ
Closed
Aug 25, 2026
Day's Range
22.8252 wk Range
15.59Overview - STAA - Staar Surgical Company
Key Statistics
Valuation
Enterprise Value
1.01B
P/E (Trailing)
‪289.25‬
P/E (Forward)
‪22.60‬
PEG Ratio
‪-2.65‬
Price / Sales (TTM)
‪3.41‬
Price / Book
‪3.26‬
EV / EBITDA
‪20.39‬
Profitability
Gross Margin
‪73.62%‬
Profit Margin
‪1.13%‬
Operating Margin
‪10.88%‬
Return on Assets
‪5.64%‬
Return on Equity
‪1.09%‬
Ownership
Shares Outstanding
49.78M
Float
26.12M
Short % of Shares Outstanding
‪21.01%‬
Held by Insiders
‪0.85%‬
Held by Institutions
‪111.61%‬
Price stats
Beta
‪1.23‬
50-Day Avg
‪26.28‬
200-Day Avg
‪24.20‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
12 analysts
Average price target
‪$ 27.90‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - STAA - Staar Surgical Company
Peers - STAA - Staar Surgical Company
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NASDAQ.
- STAANASDAQStaar Surgical Company1.16BMarket Cap-18.51%52-week change289.25P/E (Trailing)‪1.13%‬Profit Margin
- ISRGNASDAQIntuitive Surgical, Inc.133.84BMarket Cap-26.95%52-week change43.49P/E (Trailing)‪28.44%‬Profit Margin
- MDLNNASDAQMedline Inc.46.68BMarket Cap-16.34%52-week change42.82P/E (Trailing)‪2.31%‬Profit Margin
- COONASDAQThe Cooper Companies, Inc.14.78BMarket Cap+2.82%52-week change64.59P/E (Trailing)‪5.57%‬Profit Margin
- ALGNNASDAQAlign Technology, Inc.11.33BMarket Cap+11.17%52-week change28.25P/E (Trailing)‪9.99%‬Profit Margin
- RGENNASDAQRepligen Corporation10.25BMarket Cap+33.68%52-week change248.79P/E (Trailing)‪5.29%‬Profit Margin
- MMSINASDAQMerit Medical Systems, Inc.5.43BMarket Cap+2.23%52-week change37.59P/E (Trailing)‪9.22%‬Profit Margin
Profile Summary - STAA - Staar Surgical Company
About
Staar Surgical Company designs, develops, manufactures, and sells implantable lenses for eye surgery, operating primarily in the ophthalmic medical devices sector. The company offers two main product categories: Implantable Collamer lenses (ICL) used in refractive surgery to correct vision problems without removing…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
